Behavioral and Lifestyle Treatment — What the Evidence Supports and When Payers Require It
Biofeedback, CBT, and relaxation training have Level A evidence — document them as complementary therapy, not primary, to avoid weakening your PA.
PA impact: This card directly affects prior authorization outcomes. Documentation language from this card can be used in PA letters and appeals.
Why this belongs in the clinical note. Biofeedback, cognitive behavioral therapy (CBT), and relaxation training have Level A evidence from the American Academy of Neurology — the same evidence quality as most oral preventive medications. Document them. A clinical note showing behavioral contributors to migraine management strengthens any PA submission because it demonstrates comprehensive care.
What the evidence supports. Biofeedback (thermal and EMG) reduces migraine frequency 30–50% in controlled trials, comparable in magnitude to propranolol. CBT addresses catastrophizing and avoidance behaviors that worsen disability independent of headache frequency — particularly relevant for patients with high disability scores but moderate attack frequency. Relaxation training (progressive muscle relaxation, diaphragmatic breathing) is effective as monotherapy for mild episodic migraine and as an adjunct for more severe presentations. Sleep hygiene, regular meal timing, and consistent exercise (150 minutes/week moderate aerobic activity) have Level B–C evidence and should be documented as part of the treatment plan even when not the primary intervention.
Note on triggers and prodrome. Current evidence suggests that some commonly reported "triggers" — particularly food cravings, neck stiffness, and mood changes — may be prodromal symptoms rather than causal factors (see Card 15). This distinction has documentation implications. Behavioral interventions remain Level A evidence and should be documented as part of comprehensive management. However, framing them as primary treatment — "patient is managing with lifestyle modification and trigger avoidance" — can weaken a PA submission by implying the condition is controllable without medication. Document behavioral approaches as complementary: "Patient is pursuing behavioral strategies including [specific interventions] as adjunctive therapy. Despite these measures, migraine frequency remains [X] days per month, supporting the need for pharmacological prevention."
When behavioral treatment isn't accessible. Many patients cannot complete behavioral treatment — no credentialed headache-specific biofeedback provider in network, financial barriers, or migraine severity that makes attending multi-week therapy impractical. These are legitimate access barriers, not patient non-compliance. Document: "No credentialed headache-specific biofeedback provider available within [X] miles; behavioral treatment not feasible at this time." This strengthens the case for moving to medication-based prevention without the payer requiring a completed behavioral trial.
Ready to run a PA?
The PA Engine applies this guidance automatically — paste a clinical note and get a complete, payer-specific PA letter in under a minute. Free, no account required.
Run a PA — free →Citations: AAN Level A guideline for behavioral treatment — Campbell JK et al., Neurology 2000;55(6):754-762 | CBT evidence — Smitherman TA et al., Headache 2014;54(2):249-260 | AHS Behavioral Self-Management — Minen MT et al., Headache 2016;56(2):205-216. doi:10.1111/head.12789 | Pavlovic JM et al., Headache 2014;54(10):1670-1679.